Baker Bros. Capital (Gp), Llc

Affiliations

  • Large Shareholder at Diadexus Inc. (DDXS), 2012-02-01
  • Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2012-01-05
  • Large Shareholder, Director at Synageva Biopharma Corp (GEVA), 2011-11-05
  • Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
  • Large Shareholder at Adolor Corp (ADLR), 2011-07-05
  • Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-07-05
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2011-07-05
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2011-07-05
  • Large Shareholder, Director at Incyte Corp (INCY), 2011-07-05
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2011-07-05
  • Large Shareholder at Viropharma Inc (VPHM), 2011-05-13
  • Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GHDX $26.35 1 $26.35 194,415 2011-06-09 Filing
GHDX $26.30 3 $78.89 194,414 2011-06-09 Filing
GHDX $26.25 45 $1,181.25 194,411 2011-06-09 Filing
GHDX $26.10 7 $182.70 194,366 2011-06-08 Filing
GHDX $26.11 5 $130.57 194,359 2011-06-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DDXS $0.22 59,340 $13,155.68 0 2012-01-27 Filing
DDXS $0.20 20,000 $4,000.00 59,340 2012-01-19 Filing
DDXS $0.21 118,800 $25,233.12 79,340 2012-01-18 Filing
ADLR $1.18 14 $16.56 2,902 2010-10-29 Filing
ADLR $1.19 33 $39.22 2,916 2010-10-28 Filing